Undecylenoyl Phenylalanine [CAS 175357-18-3]

Undecylenoyl Phenylalanine [CAS 175357-18-3]

Discover YLAminoBright (Undecylenoyl Phenylalanine), an alpha-MSH antagonist targeting melanin signalling. Highly effective at low use levels (0.2-2%) for skin brightening. Available in 1KG.

Brand:

Description

What is Undecylenoyl Phenylalanine?
YLAminoBright is the product code for Undecylenoyl Phenylalanine (CAS 175357-18-3), an advanced, highly targeted skincare active. It functions as an alpha-MSH (Melanocyte-Stimulating Hormone) antagonist. Instead of irritating the skin or exfoliating it, YLAminoBright works by intercepting the biological signals that trigger melanin production. It specifically targets melanin signalling pathways, making it exceptionally effective at low use levels for brightening and evening out skin tone.


Key Benefits

  • Targets Melanin Signalling: Acts as a specific alpha-MSH antagonist to block the root causes of hyperpigmentation and excess melanin production at the cellular level.

  • Effective at Low Use Levels: Clinically highly potent, requiring only a suggested addition of 0.2% to 2% to achieve visible brightening effects, making it highly cost-effective.

  • Non-Irritating Mechanism: Unlike traditional acids, it does not rely on exfoliation or cause skin peeling, making it gentle enough for sensitive skin and daily use.

  • Brightens & Evens Skin Tone: Effectively reduces the appearance of dark spots, hyperpigmentation, and uneven skin tone for a luminous complexion.


FAQ
Q: What is the recommended usage rate for YLAminoBright?
A: The suggested addition rate for this ingredient is between 0.2% and 2%. It is specifically designed to be effective at these low use levels.

Q: How does Undecylenoyl Phenylalanine work?
A: It works as an alpha-MSH antagonist. It targets and blocks melanin signalling pathways, preventing the skin from producing excess melanin without causing irritation.

Reviews

There are no reviews yet.

Be the first to review “Undecylenoyl Phenylalanine [CAS 175357-18-3]”

Your email address will not be published. Required fields are marked *